secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2023-04-12T23:59:59+00:00
Accession:  0001104659-23-044380
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health enters $100M pre-paid advance with Yorkville; initial $15M at 90% of face
--------------------------------------------------------------------------------

- Aggregate commitment $100M over 18 months; initial $15M funded, second $10M contingent on VWAP >= $0.60.
- Purchase price 90% of face; conversion price floor $0.1851; shares issued at lower of VWAP or 92% of two lowest daily VWAPs.
- Yorkville capped at 4.99% beneficial ownership; aggregate issuances limited to 19.9% of shares (Nasdaq Cap); no short sales.
- Lincoln Park Capital waives its equity line while PPA outstanding >$1M; Nutex agrees not to terminate LPCF for 24 months.
- Proceeds to support growth, acquisitions, potential stock buybacks, and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000110465923044380/0001104659-23-044380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000110465923044380/tm2310592d8_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-044380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer